AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
Log in

NASDAQ:SRNESorrento Therapeutics Earnings Date, Estimates & History

$7.38
+0.21 (+2.93 %)
(As of 07/7/2020 02:06 PM ET)
Add
Compare
Today's Range
$6.97
Now: $7.38▼
$7.44
50-Day Range
$3.86
MA: $5.26▼
$6.93
52-Week Range
$1.39
Now: $7.38▼
$10.00
Volume731,699 shs
Average Volume26.65 million shs
Market Capitalization$1.55 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.17

Earnings

Sorrento Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 14th, 2020 based off prior year's report dates.

Sorrento Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Sorrento Therapeutics (NASDAQ:SRNE) Earnings Estimates

2020 EPS Consensus Estimate: ($1.06)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.34)($0.34)($0.34)
Q2 20201($0.26)($0.26)($0.26)
Q3 20201($0.25)($0.25)($0.25)
Q4 20201($0.21)($0.21)($0.21)

Sorrento Therapeutics (NASDAQ SRNE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/14/2020
(Estimated)		       
3/2/2020Q4 2019($0.41)($0.41)($0.41)$7.00 million$13.03 millionN/A
11/8/2019Q3 2019($0.42)($0.42)($0.34)$7.70 million$5.78 millionN/A
8/9/2019Q2 2019($0.40)($0.39)($0.31)$7.50 million$6.48 millionN/A
5/15/2019Q1 2019($0.35)($0.30)$0.28$8.02 million$6.14 millionN/A
3/15/2019Q4 2018($0.40)($0.40)$6.93 millionN/A
11/9/2018Q3 2018($0.40)($0.40)$4.11 millionN/A
8/9/2018Q2 2018($0.20)($0.73)($0.73)$3.28 million$3.91 millionN/A
5/10/2018Q1 2018($0.38)($0.38)$6.25 millionN/A
3/16/2018Q4 2017$0.72$0.72$20.41 millionN/A
11/9/2017Q3 2017$0.44$0.44$121.91 millionN/A
8/9/2017Q2 2017($0.20)($0.20)$4.67 millionN/A
5/15/2017Q1 2017($0.33)($0.45)($0.45)$4.02 million$4.87 millionN/A
3/21/2017Q4 2016($0.27)($0.44)($0.58)$2.99 million$4.02 millionN/A
11/9/2016Q3 2016($0.19)($0.60)$2.24 millionN/A
8/8/2016Q2 2016($0.17)($0.28)$0.41$1.11 million$0.90 millionN/A
5/10/2016Q1 2016($0.37)($0.63)($0.78)$1.34 million$0.99 millionN/A
3/15/2016Q4 2015($0.63)($0.63)$1.34 millionN/A
11/16/2015Q3 2015($0.37)($0.82)($1.61)$1.28 million$1.10 millionN/A
8/7/2015Q2 2015($0.32)($0.30)($0.30)$0.95 million$1.17 millionN/A
5/5/2015Q1 2015($0.14)($0.29)($0.29)$5.85 million$0.98 millionN/A
3/13/2015Q4 2014($0.28)($0.28)$0.80 millionN/A
11/4/2014Q3 2014($0.34)($0.27)($0.27)$0.08 million$1.28 millionN/A
8/6/2014Q2 2014($0.34)($0.33)($0.33)$0.08 million$0.78 millionN/A
5/14/2014Q1 2014($0.29)($0.44)($0.44)$0.12 million$0.98 millionN/A
4/1/2014Q4 2013($0.28)($0.35)($0.04)$0.10 millionN/A
11/14/2013Q3 2013($0.28)($0.23)($0.22)$0.08 millionN/A
8/13/2013Q2 2013($0.26)($0.17)$0.14 millionN/A
5/15/2013Q1 2013($0.01)($0.01)$0.13 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.